Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...

First approved by the US FDA in 2014 for advanced skin cancer, Keytruda is now used globally for certain lung cancers, ...

A cross-border investigation by DW and ICIJ reveals how pricing and patents helped turn a life-saving medicine into one of ...

A study published April 10 in The Lancet reports that the anti-PD-1 immunotherapy pembrolizumab (brand name Keytruda) ...

Late-Phase Research Presented at Society of Gynecologic Oncology Annual Meeting FORT MYERS, Fla., April 13, 2026 /PRNewswire/ -- Late-phase clinical research conducted with participation from Florida ...

Some of the philanthropic foundations that fund ICIJ have programs or campaigns advocating for reform of the pharmaceutical ...

In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.

We reveal how the bullish tactics of a pharma giant have left taxpayers spending over the odds for its life-saving medicine ...

Globally approved for scores of cancers, the company's patient access programme in India supports it for 10 types of cancer, ...

The KEYNOTE-671 trial showed a 71% 36-month overall survival rate with perioperative Keytruda, compared to 64% with placebo. FDA approvals for Keytruda, Imfinzi, and Opdivo in perioperative settings ...

India Keytruda cancer drug scam exposes counterfeit vials sold to desperate patients, probe reveals hospital insiders, black ...

Jodi McNamara has learned a lot of tricks — and sheer determination — help her fight insurance to get her husband the best ...